| Republic of Korea | Thailand | Turkey | |
| Removal of liver cancer | from AUD $16,105 | from AUD $27,888 | from AUD $15,059 |
| Radiofrequency ablation of the liver | from AUD $8,645 | from AUD $7,669 | from AUD $4,880 |
| Chemoembolization of the liver | from AUD $6,693 | from AUD $10,458 | from AUD $10,458 |
| Chemotherapy for liver cancer | from AUD $4,183 | - | from AUD $3,904 |
No hidden fees – just official clinic prices. Pay at the clinic for Metastases in the liver treatment and use a flexible instalment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Metastases in the liver treatment and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Metastases in the liver treatment journey.
Professor Lee Seok-gu is a leading liver transplant surgeon at Myongji Hospital. He has performed about 2,000 liver transplants. He achieved Korea’s first transfusion-free liver transplant. He performed hepatocyte transplantation in a one-month-old infant. He led the first clinical use of a bioartificial liver for acute liver failure. He also performed living-donor transplants in Egypt and trained teams in Vietnam.
He is Professor of Surgery at Myongji Hospital and former Director of the Organ Transplantation Center at Samsung Medical Center. He earned his MD and MSc from Seoul National University and his PhD from the Catholic University of Korea. He completed a fellowship at Boston Children’s Hospital/Harvard and transplant training at Johns Hopkins. He served as president of three national societies in transplantation and pediatric surgery. His honors include the Chong Kun Dang Award, the Pfizer Clinical Medicine Award, and the Astellas Investigator Award. He has 447 publications and 13 book chapters.
Surgery for liver metastases is possible in South Korea, particularly for patients with colorectal cancer. Specialists perform liver resection when tumours are confined or limited. Major Seoul centres use multi-step treatments. They combine surgery with chemotherapy or radiofrequency ablation to clear metastatic disease.
Bookimed Expert Insight: South Korea's highest-volume hospitals, such as Asan Medical Center, report a 98% liver transplant success rate. This level of hepatobiliary expertise translates directly to complex metastatic surgery. Patients often find that Seoul university hospitals achieve higher anus-preservation rates in colon-to-liver cases than many Western institutions.
Patient Consensus: Patients note that major Seoul hospitals require extensive disease verification before planning surgery. Experience shows that resection is most successful when the disease responds well to chemotherapy first.
South Korean hospitals treat liver metastasis. They use surgical resection, proton beam therapy, and targeted systemic treatments. Major centres like Samsung Medical Center and Asan Medical Center employ multidisciplinary teams. They specialise in laparoscopic liver surgery and interventional techniques. These techniques are for complex colorectal and gastric cancer cases.
Bookimed Expert Insight: South Korea leads in surgical volume. Seoul National University Hospital performs over 1,000 liver transplants. This high volume translates to exceptional technical proficiency in complex liver resections. These resections often involve major blood vessels. Patients with advanced cases benefit from this experience. Surgeons here often successfully resect tumours that other centres might deem inoperable.
Patient Consensus: Patients note that major Seoul hospitals provide fast-tracked consultations and diagnostic tests for international arrivals. They emphasise that these centres are busy. However, the multidisciplinary approach means every specialist reviews the case together.
South Korean clinics use immunotherapy and targeted therapy as primary treatments for liver metastases. Specialists often combine these systemic therapies with local procedures like TACE. Major centres in Seoul hold JCI and ISO accreditations. This means patients receive care that meets strict international safety standards.
Bookimed Expert Insight: South Korean oncology stands out because major hospitals report high success rates. Asan Medical Center, for instance, reports a 98% liver transplant success rate. This hepatobiliary expertise means their medical teams are skilled at managing complex liver function. They apply this during intensive immunotherapy cycles. Patients benefit from this deep surgical and physiological knowledge. They gain from it even when only receiving drug-based treatments.
Patient Consensus: Patients note that Korean medical teams prioritise mutation testing. This helps select the most effective drug combinations. They appreciate the focus on managing fatigue while tumours shrink. However, they emphasise the need to monitor liver function closely during treatment in South Korea.
TACE and radioembolisation are minimally invasive procedures that target liver tumours through their blood supply. South Korean specialists use TACE to trap chemotherapy inside tumours. Radioembolisation (TARE) delivers high-dose radiation via Yttrium-90 beads. These are preferred for metastatic cases where surgery is not possible.
Bookimed Expert Insight: South Korea's leadership in liver treatment stems from massive surgical volumes. Severance Hospital alone handles 40,000 operations annually. This high frequency allows interventional radiologists to refine superselective techniques. Patients often find that combining TACE with regional therapies yields better tumour shrinkage than single-modality treatment. Samsung Medical Center, for example, provides such combined therapies.
Patient Consensus: Patients note that while the procedures can cause temporary discomfort, they often lead to reduced cancer markers and improved wellbeing. Those treated in Seoul suggest discussing pain management upfront. They also confirm these therapies work best when the disease is primarily confined to the liver.
South Korean clinics provide world-leading care for colorectal liver metastases. They report 5-year survival rates that exceed those in Australia and the United States. Specialist centres like Samsung Medical Center use proton beam therapy and robotic liver resection. These methods treat complex secondary tumours.
Bookimed Expert Insight: Clinical data shows a shift towards minimally invasive techniques in Seoul. Seoul National University Bundang Hospital performs 90% of certain oncology surgeries laparoscopically. This includes world-first paediatric liver resections. For Australian patients, this technical mastery means two things: shorter hospital stays and faster recovery. These are significant improvements over traditional open surgery.
Patient Consensus: Patients often mention the incredible efficiency of the diagnostic process in Seoul. They appreciate getting PET-CT scans and specialist consultations within days rather than weeks. Many note the calm, hotel-like environment of centres like Samsung Medical Center. This helps reduce treatment stress.
Patients typically stay 1 to 2 weeks for minimally invasive liver metastases treatments. These include chemoembolisation or ablation. Major surgeries require a longer stay of 1 to 2 months. These include liver resection or transplantation. JCI-accredited Seoul centres often conduct diagnostic assessments during the first week.
Bookimed Expert Insight: Korea University Anam Hospital offers same-day consultations and tests for new cancer patients. This protocol can significantly reduce the usual 1-week waiting period for initial assessments. Australian patients should look for clinics with this "One-Stop" service. It helps cut down on total travel time and accommodation costs in Seoul.
Patient Consensus: Patients note that Korean medical teams often repeat all pathology and diagnostic scans upon arrival. Bringing translated records helps. Even so, most treat it as a multi-week commitment, not a quick medical holiday.